Company News
Nuvectis Pharma Shares Fall 20.5% on Offering
Nuvectis Pharma announced an underwritten public offering of its common stock, with Cantor as sole book runner.
Shares fell 20.5% in after‑hours trading on Monday following the announcement, reflectin
